FUJIFILM Toyama Chemical Co. Submits Application for Avigan (Favipiravir) Approval for COVID-19 to Japan’s Health Authority

FUJIFILM Toyama Chemical Co. Submits Application for Avigan (Favipiravir) Approval for COVID-19 to Japan's Health Authority

Japan’s FUJIFILM Toyama Chemical Co., Ltd announced that the company filed an Application for Partial Changes to manufacturing and marketing approval matters of its anti-influenza drug Avigan® Tablet (Favipiravir) to the Ministry of Health, Labor and Welfare in Japan. The filing seeks to add an indication and other items relating to novel coronavirus infections (COVID-19). This antiviral drug, originating in Japan, has already been approved in Russia and India, at least on an emergency basis, for COVID-19.

TrialSite News has chronicled a good amount of activity associated with Favipiravir. What follows is a brief breakdown of the news, the drug and status elsewhere.

What is Avigan?

Known by the generic name Favipiravir, Avigan is already approved, since 2014, for manufacture and sale in Japan as an influenza antiviral drug as it selectively inhibits RNA polymerase necessary for influenza viral replication.

What’s the basis for pursuing approval for treating COVID-19?

As Avigan selectively inhibits viral replication it has been sought that it may have an antiviral effect on SARS-CoV-2, the virus behind COVID-19; this novel coronavirus is a RNA virus of a similar...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee